Obulytix

Obulytix leverages phage-derived lysins, enzymes that rapidly cleave bacterial cell walls with extraordinary specificity. It develops Precision Lysin Therapeutics (PLTs), targeted biologics engineered to selectively kill bacteria without fueling antimicrobial resistance.